ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $126,000 | -6.0% | 11,002 | +0.6% | 0.00% | – |
| Q3 2017 | $134,000 | +3.1% | 10,936 | -3.6% | 0.00% | – |
| Q2 2017 | $130,000 | -65.6% | 11,342 | -37.6% | 0.00% | -100.0% |
| Q1 2017 | $378,000 | +6.2% | 18,189 | +6.3% | 0.00% | 0.0% |
| Q4 2016 | $356,000 | -36.4% | 17,113 | +0.1% | 0.00% | -50.0% |
| Q3 2016 | $560,000 | +54.3% | 17,088 | +17.7% | 0.00% | +100.0% |
| Q2 2016 | $363,000 | +28.3% | 14,520 | +25.6% | 0.00% | 0.0% |
| Q1 2016 | $283,000 | -27.4% | 11,564 | -2.0% | 0.00% | 0.0% |
| Q4 2015 | $390,000 | +4.3% | 11,801 | +3.5% | 0.00% | -50.0% |
| Q3 2015 | $374,000 | – | 11,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $37,365,000 | 8.14% |
| Foresite Capital Management II, LLC | 1,686,220 | $21,415,000 | 7.12% |
| Foresite Capital Management IV, LLC | 830,919 | $10,553,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 822,890 | $10,451,000 | 3.30% |
| Redmile Group, LLC | 6,505,766 | $82,623,000 | 3.19% |
| DAFNA Capital Management LLC | 396,013 | $5,029,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 863,600 | $10,968,000 | 1.20% |
| Palo Alto Investors LP | 1,849,832 | $23,493,000 | 1.00% |
| Bellevue Group AG | 700,464 | $8,896,000 | 0.88% |
| Rock Springs Capital Management LP | 1,529,800 | $19,428,000 | 0.83% |